August 12, 2017

FDA Issues Guidance on Streamlining Development of Antibacterial Drugs for Patients with Unmet Needs

The Center for Drug Evaluation and Research released final guidance on the development of new antibacterial drugs to treat serious bacterial diseases in patients with an unmet medical need.

The guidance, which finalizes draft guidanc...

You must be a subscriber to access this information. If you are a subscriber, please login. Not Yet A Subscriber? Click here to register for a free trial or contact Client Services at 800-677-3789 to activate your subscription.

Feedback Form
Leads to Insight